Bluejay Diagnostics Analyst Ratings
Bluejay Diagnostics Analyst Ratings
While ratings are subjective and will change, the latest Bluejay Diagnostics (BJDX) rating was a downgraded with a price target of $0.00 to $0.00. The current price Bluejay Diagnostics (BJDX) is trading at is $9.70, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/03/2023 | — | Dawson James | Downgrades | Buy → Neutral | |
| 01/12/2022 | 3.05% | Dawson James | → $10 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 08/03/2023 | — | 道森·詹姆斯 | 降级 | 买入 → 中性 | |
| 2022 年 12 月 1 日 | 3.05% | 道森·詹姆斯 | → 10 美元 | 启动覆盖开启 | → 购买 |
What is the target price for Bluejay Diagnostics (BJDX)?
Bluejay Diagnostics（BJDX）的目标价格是多少？
The latest price target for Bluejay Diagnostics (NASDAQ: BJDX) was reported by Dawson James on August 3, 2023. The analyst firm set a price target for $0.00 expecting BJDX to fall to within 12 months (a possible -100.00% downside). 1 analyst firms have reported ratings in the last year.
道森·詹姆斯于2023年8月3日公布了Bluejay Diagnostics（纳斯达克股票代码：BJDX）的最新目标股价。这家分析公司将目标股价定为0.00美元，预计BJDX将在12个月内跌至-100.00％（可能下跌-100.00％）。去年有1家分析公司公布了评级。
What is the most recent analyst rating for Bluejay Diagnostics (BJDX)?
分析师对Bluejay Diagnostics（BJDX）的最新评级是多少？
The latest analyst rating for Bluejay Diagnostics (NASDAQ: BJDX) was provided by Dawson James, and Bluejay Diagnostics downgraded their neutral rating.
Bluejay Diagnostics（纳斯达克股票代码：BJDX）的最新分析师评级由道森·詹姆斯提供，Bluejay Diagnostics下调了中性评级。
When is the next analyst rating going to be posted or updated for Bluejay Diagnostics (BJDX)?
Bluejay Diagnostics（BJDX）的下一个分析师评级何时公布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bluejay Diagnostics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bluejay Diagnostics was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.
分析师在进行了广泛的研究，包括浏览公开财务报表、与Bluejay Diagnostics的高管和客户交谈以及听取财报电话会议后得出股票评级。大多数分析师每三个月进行一次评级，因此每家公司每年应该获得4个评级。Bluejay Diagnostics 的最后评级是在2023年8月3日提交的，因此你应该预计下一个评级将在2024年8月3日左右公布。
Is the Analyst Rating Bluejay Diagnostics (BJDX) correct?
分析师评级 Bluejay Diagnostics (BJDX) 正确吗？
While ratings are subjective and will change, the latest Bluejay Diagnostics (BJDX) rating was a downgraded with a price target of $0.00 to $0.00. The current price Bluejay Diagnostics (BJDX) is trading at is $9.70, which is out of the analyst's predicted range.
虽然评级是主观的，会发生变化，但最新的Bluejay Diagnostics（BJDX）评级被下调，目标股价为0.00美元至0.00美元。Bluejay Diagnostics（BJDX）目前的交易价格为9.70美元，超出了分析师的预测区间。
